David Larsen

BTIG | Healthcare

David Larsen is an analyst from BTIG specializing in the Healthcare sector. Ranked #1685 out of 4786 analysts, they have issued 56 stock ratings with a success rate of 85.72% and an average return of 15.79%.

David Larsen has a well-established track record, with 56 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 85.72% and an average return of 15.79%, underscoring their expertise and ability to identify winning opportunities for investors.

#1685

Out of 4786

56

Total Ratings

+85.72%

Success Rate

+15.79%

Average Return

Recent Ratings Analysis

CCSI

Sep 25, 2026

Target

$50.00

Current

$35.22

Performance

0.00%

David Larsen rated CCSI as Buy on Sep 25, 2026, setting a price target of 50. Shares have remained stable near 35.22, leaving the 50 target still in play.

LFST

Aug 19, 2026

Target

$18.00

Current

$11.84

Performance

-7.72%

On Aug 19, 2026, LFST was given a Buy rating by David Larsen, with a target price of 18. Despite the Buy call, shares fell from 11.84 to 11.84, challenging the optimistic stance.

HSIC

Aug 19, 2026

Target

$110.00

Current

$86.37

Performance

-3.27%

HSIC received a Buy rating from David Larsen on Aug 19, 2026, aiming for 110. Price action was muted, as shares hovered around 86.37 despite the bullish outlook.

BTSG

Aug 03, 2026

Target

$90.00

Current

$56.59

Performance

-6.42%

On Aug 03, 2026, David Larsen published a Buy outlook on BTSG, with a target of 90. Market action contradicted the Buy thesis, as shares slipped to 56.59.

MDLN

Jul 31, 2026

Target

$55.00

Current

$34.70

Performance

-11.66%

David Larsen on Jul 31, 2026 assigned MDLN a Buy rating, with a price target of 55. The call has struggled to gain traction, with shares losing 11.66%.

HQY

Jul 24, 2026

Target

$115.00

Current

$88.25

Performance

-6.75%

On Jul 24, 2026, David Larsen reaffirmed HQY with a Buy rating, targeting 115. Shares slid 6.75% despite the recommendation, highlighting downside risks.

PGNY

Jul 24, 2026

Target

$40.00

Current

$25.44

Performance

-18.44%

PGNY was rated Buy by David Larsen on Jul 24, 2026, with a price objective of 40. This case shows how bullish projections can fail, with the stock now below 25.44.

CYRX

Jul 24, 2026

Target

$25.00

Current

$17.41

Performance

13.27%

On Jul 24, 2026, David Larsen initiated coverage on CYRX with a Buy rating and target of 25. The stock’s climb of 13.27% since the call highlights the foresight in the rating.

OMDA

Jul 17, 2026

Target

$30.00

Current

$19.66

Performance

-17.05%

David Larsen issued a Buy recommendation for OMDA on Jul 17, 2026, price target set at 30. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

TOI

Jul 09, 2026

Target

$9.00

Current

$5.13

Performance

-12.31%

On Jul 09, 2026, TOI was evaluated by David Larsen, who gave a Buy rating and target of 9. Investors saw limited payoff as shares fell short of the 9 target.

VEEV

Jun 04, 2026

Target

$340.00

Current

$280.68

Performance

57.16%

David Larsen rated VEEV as Buy on Jun 04, 2026, setting a price target of 340. The call has proven timely, with shares rising 57.16% toward the price target of 340.

ASTH

Jun 02, 2026

Target

$50.00

Current

$36.37

Performance

—

On Jun 02, 2026, ASTH was given a Buy rating by David Larsen, with a target price of 50. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

LFMD

May 04, 2026

Target

$10.00

Current

$2.97

Performance

-41.65%

LFMD received a Buy rating from David Larsen on May 04, 2026, aiming for 10. The rating hasn’t played out as hoped, with the stock trading 41.65% below expectations.

EVH

Feb 25, 2026

Target

$10.00

Current

$3.61

Performance

14.97%

On Feb 25, 2026, David Larsen published a Buy outlook on EVH, with a target of 10. Shares gained 14.97%, underscoring the accuracy of the bullish outlook toward 10.

HIMS

Feb 24, 2026

Target

—

Current

$29.42

Performance

90.30%

David Larsen on Feb 24, 2026 assigned HIMS a Neutral rating, with a price target of null. Shares outperformed expectations, climbing 90.30% despite the neutral view.

DOCS

Feb 06, 2026

Target

$50.00

Current

$26.35

Performance

-4.98%

On Feb 06, 2026, David Larsen reaffirmed DOCS with a Buy rating, targeting 50. Market indecision has kept the 50 target in a holding pattern.

SLP

Dec 18, 2025

Target

—

Current

$18.46

Performance

—

SLP was rated Neutral by David Larsen on Dec 18, 2025, with a price objective of null. Flat performance suggests the Hold view was reasonable.

PIII

Dec 12, 2025

Target

—

Current

$7.05

Performance

35.84%

On Dec 12, 2025, David Larsen initiated coverage on PIII with a Neutral rating and target of null. The Hold stance underestimated the stock’s strength as it gained 35.84%.

AGL

Dec 12, 2025

Target

—

Current

$80.73

Performance

349.12%

David Larsen issued a Neutral recommendation for AGL on Dec 12, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

HCAT

Sep 05, 2025

Target

—

Current

$1.74

Performance

-48.52%

On Sep 05, 2025, HCAT was evaluated by David Larsen, who gave a Neutral rating and target of null. The Hold call avoided chasing into subsequent weakness of 48.52%.

DH

Sep 17, 2024

Target

$7.00

Current

$0.94

Performance

-80.06%

David Larsen rated DH as Buy on Sep 17, 2024, setting a price target of 7. The stock has underperformed, dropping 80.06% despite the bullish target of 7.

DCGO

May 09, 2024

Target

$7.00

Current

$0.34

Performance

-88.81%

On May 09, 2024, DCGO was given a Buy rating by David Larsen, with a target price of 7. Despite the Buy call, shares fell from 0.3445 to 0.3445, challenging the optimistic stance.

Frequency Asked Questions

Who is David Larsen?

David Larsen is an analyst from BTIG specializing in the Healthcare sector.

What is David Larsen's success rate?

David Larsen currently has a success rate of +85.72%.

How many ratings has David Larsen issued?

David Larsen has issued 56 stock ratings so far.

What is the average return of David Larsen's calls?

Their stock ratings have generated an average return of +15.79%.

What is David Larsen's ranking?

David Larsen is ranked #1685 out of 4786 analysts.

What types of ratings does David Larsen give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Larsen?

You can follow David Larsen by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Larsen?

Their latest rating was a Buy on CCSI issued on 2026-09-25.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep